|
PCNT expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.636300E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.767700E-02 |
| Normal-vs-Stage2 |
1.788230E-02 |
| Normal-vs-Stage3 |
8.638100E-03 |
| Normal-vs-Stage4 |
2.956200E-03 |
| Stage1-vs-Stage2 |
2.807400E-01 |
| Stage1-vs-Stage3 |
2.272800E-01 |
| Stage1-vs-Stage4 |
1.188370E-01 |
| Stage2-vs-Stage3 |
9.061400E-01 |
| Stage2-vs-Stage4 |
8.440000E-01 |
| Stage3-vs-Stage4 |
7.176200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.336200E-03 |
| Normal-vs-AfricanAmerican |
4.827800E-01 |
| Normal-vs-Asian |
7.505600E-01 |
| Caucasian-vs-AfricanAmerican |
2.037400E-01 |
| Caucasian-vs-Asian |
4.774800E-01 |
| AfricanAmerican-vs-Asian |
9.450200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.042400E-03 |
| Normal-vs-Female |
9.835700E-02 |
| Male-vs-Female |
4.588200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.120820E-01 |
| Normal-vs-Age(41-60Yrs) |
1.266020E-01 |
| Normal-vs-Age(61-80Yrs) |
8.040100E-04 |
| Normal-vs-Age(81-100Yrs) |
1.054430E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.707200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.914200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.394800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.730100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.450190E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.957400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.898300E-02 |
| Normal-vs-Grade 2 |
4.504100E-02 |
| Normal-vs-Grade 3 |
2.364500E-03 |
| Normal-vs-Grade 4 |
3.963100E-03 |
| Grade 1-vs-Grade 2 |
3.556800E-03 |
| Grade 1-vs-Grade 3 |
5.769300E-04 |
| Grade 1-vs-Grade 4 |
5.040600E-04 |
| Grade 2-vs-Grade 3 |
1.406240E-01 |
| Grade 2-vs-Grade 4 |
1.577360E-01 |
| Grade 3-vs-Grade 4 |
7.320600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.325500E-02 |
| Normal-vs-ccB subtype |
3.299100E-03 |
| ccA subtype-vs-ccB subtype |
1.029230E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.097860E-02 |
| Normal-vs-N1 |
9.393900E-02 |
| N0-vs-N1 |
7.984600E-01 |
|
|
